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Abstract
A cornerstone of biotechnology is the use of microorganisms for the efficient production of chemicals and the elimination
of harmful waste. Pseudomonas putida is an archetype of such microbes due to its metabolic versatility, stress resistance,
amenability to genetic modifications, and vast potential for environmental and industrial applications. To address both the
elucidation of the metabolic wiring in P. putida and its uses in biocatalysis, in particular for the production of non-growth-
related biochemicals, we developed and present here a genome-scale constraint-based model of the metabolism of P.
putida KT2440. Network reconstruction and flux balance analysis (FBA) enabled definition of the structure of the metabolic
network, identification of knowledge gaps, and pin-pointing of essential metabolic functions, facilitating thereby the
refinement of gene annotations. FBA and flux variability analysis were used to analyze the properties, potential, and limits of
the model. These analyses allowed identification, under various conditions, of key features of metabolism such as growth
yield, resource distribution, network robustness, and gene essentiality. The model was validated with data from continuous
cell cultures, high-throughput phenotyping data,
13C-measurement of internal flux distributions, and specifically generated
knock-out mutants. Auxotrophy was correctly predicted in 75% of the cases. These systematic analyses revealed that the
metabolic network structure is the main factor determining the accuracy of predictions, whereas biomass composition has
negligible influence. Finally, we drew on the model to devise metabolic engineering strategies to improve production of
polyhydroxyalkanoates, a class of biotechnologically useful compounds whose synthesis is not coupled to cell survival. The
solidly validated model yields valuable insights into genotype–phenotype relationships and provides a sound framework to
explore this versatile bacterium and to capitalize on its vast biotechnological potential.
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Introduction
Pseudomonas putida is one of the best studied species of the
metabolically versatile and ubiquitous genus of the Pseudomonads
[1–3]. As a species, it exhibits a wide biotechnological potential,
with numerous strains (some of which solvent-tolerant [4,5]) able
to efficiently produce a range of bulk and fine chemicals. These
features, along with their renowned stress resistance, amenability
for genetic manipulation and suitability as a host for heterologous
expression, make Pseudomonas putida particularly attractive for
biocatalysis. To date, strains of P. putida have been employed to
produce phenol, cinnamic acid, cis-cis-muconate, p-hydroxy-
benzoate, p-cuomarate, and myxochromide [6–12]. Furthermore,
enzymes from P. putida have been employed in a variety of other
biocatalytic processes, including the resolution of D/L-phenylgly-
cinamide into D-phenylglycinamide and L-phenylglycine, produc-
tion of non-proteinogenic L-amino acids, and biochemical
oxidation of methylated heteroaromatic compounds for formation
of heteroaromatic monocarboxylic acids [13]. However, most
Pseudomonas-based applications are still in infancy largely due to
a lack of knowledge of the genotype-phenotype relationships in
these bacteria under conditions relevant for industrial and
environmental endeavors. In an effort towards the generation of
critical knowledge, the genomes of several members of the
Pseudomonads have been or are currently being sequenced
(http://www.genomesonline.org, http://www.pseudomonas.com),
and a series of studies are underway to elucidate specific aspects of
their genomic programs, physiology and behavior under various
stresses (e.g., http://www.psysmo.org, http://www.probactys.org,
http://www.kluyvercentre.nl).
The sequencing of P. putida strain KT2440, a workhorse of P.
putida research worldwide and a microorganism Generally
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investigate the metabolic potential of the P. putida species, and
opened avenues for the development of new biotechnological
applications [2,14–16]. Whole genome analysis revealed, among
other features, a wealth of genetic determinants that play a role in
biocatalysis, such as those for the hyper-production of polymers
(such as polyhydroxyalkanoates [17,18]) and industrially relevant
enzymes, the production of epoxides, substituted catechols,
enantiopure alcohols, and heterocyclic compounds [13,15].
However, despite the clear breakthrough in our understanding
of P. putida through this sequencing effort, the relationship between
the genotype and the phenotype cannot be predicted simply from
cataloguing and assigning gene functions to the genes found in the
genome, and considerable work is still needed before the genome
can be translated into a fully functioning metabolic model of value
for predicting cell phenotypes [2,14].
Constraint-based modeling is currently the only approach that
enables the modeling of an organism’s metabolic and transport
network at genome-scale [19]. A genome-wide constraint-based
model consists of a stoichiometric reconstruction of all reactions
known to act in the metabolism of the organism, along with an
accompanying set of constraints on the fluxes of each reaction in
the system [19,20]. A major advantage of this approach is that the
model does not require knowledge on the kinetics of the reactions.
These models define the organism’s global metabolic space,
network structural properties, and flux distribution potential, and
provide a framework with which to navigate through the
metabolic wiring of the cell [19–21].
Through various analysis techniques, constraint-based models
can help predict cellular phenotypes given particular environmen-
tal conditions. Flux balance analysis (FBA) is one such technique,
which relies on the optimization for an objective flux while
enforcing mass balance in all modeled reactions to achieve a set of
fluxes consistent with a maximal output of the objective function.
When a biomass sink is chosen as the objective in FBA, the output
can be correlated with growth, and the model fluxes become
predictive of growth phenotypes [22,23]. Constraint-based analysis
techniques, including FBA, have been instrumental in elucidating
metabolic features in a variety of organisms [20,24,25] and, in a
few cases thus far, they have been used for concrete biotechnology
endeavors [26–29].
However, in all previous applications in which a constraint-
based approach was used to design the production of a
biochemical, the studies addressed only the production of
compounds that can be directly coupled to the objective function
used in the underlying FBA problem. The major reason for this is
that FBA-based methods predict a zero-valued flux for any
reaction not directly contributing to the chosen objective. Since
the production pathways of most high-added value and bulk
compounds operate in parallel to growth-related metabolism,
straightforward application of FBA to these biocatalytic processes
fails to be a useful predictor of output. Other constraint-based
analysis methods, such as Extreme Pathways and Elementary
Modes analysis, are capable of analyzing non-growth related
pathways in metabolism, but, due to combinatorial explosion
inherent to numerical resolution of these methods, they could not
be used so far to predict fluxes or phenotypes at genome-scale for
guiding biocatalysis efforts [30].
To address both the elucidation of the metabolic wiring in P.
putida and the use of P. putida for the production of non-growth-
related biochemicals, we developed and present here a genome-
scale reconstruction of the metabolic network of Pseudomonas putida
KT2440, the subsequent analysis of its network properties through
constraint-based modeling and a thorough assessment of the
potential and limits of the model. The reconstruction is based on
up-to-date genomic, biochemical and physiological knowledge of
the bacterium. The model accounts for the function of 877
reactions that connect 886 metabolites and builds upon a
constraint-based modeling framework [19,20]. Only 6% of the
reactions in the network are non gene-associated. The reconstruc-
tion process guided the refinement of the annotation of several
genes. The model was validated with continuous culture
experiments, substrate utilization assays (BIOLOG) [31],
13C-
measurement of internal fluxes [32], and a specifically generated
set of mutant strains. We evaluated the influence of biomass
composition and maintenance values on the outcome of flux
balance analysis (FBA) simulations, and utilized the metabolic
reconstruction to predict internal reaction fluxes, to identify
different mass-routing possibilities, and to determine necessary
gene and reaction sets for growth on minimal medium. Finally, by
means of a modified OptKnock approach, we utilized the model
to generate hypotheses for possible improvements of the
production by P. putida of polyhydroxyalkanoates, a class of
compounds whose production consumes resources that would be
otherwise used for growth. This reconstruction thus provides a
modeling framework for the exploration of the metabolic
capabilities of P. putida, which will aid in deciphering the complex
genotype-phenotype relationships governing its metabolism and
will help to broaden the applicability of P. putida strains for
bioremediation and biotechnology.
Results
Highlights of the Model Reconstruction Process
We reconstructed the metabolism of P. putida at the genome-
scale through a process summarized in Figure 1. The reconstruc-
tion process involved: (1) an initial data collection stage leading to
a first pass reconstruction (iJP815
pre1); (2) a model building stage in
which simulations were performed with iJP815
pre1 and reactions
were added until the model was able to grow in silico on glucose
minimal medium (iJP815
pre2); and (3) a model completion stage in
which BIOLOG substrate utilization data was used to guide model
expansion and in silico viability on varied substrates. The final
Author Summary
The pseudomonads include a diverse set of bacteria whose
metabolic versatility and genetic plasticity have enabled
their survival in a broad range of environments. Many
members of this family are able to either degrade toxic
compounds or to efficiently produce high value com-
pounds and are therefore of interest for both bioremedia-
tion and bulk chemical production. To better understand
the growth and metabolism of these bacteria, we devel-
oped a large-scale mathematical model of the metabolism
of Pseudomonas putida, a representative of the industrially
relevant pseudomonads. The model was initially expanded
and validated with substrate utilization data and carbon-
tracking data. Next, the model was used to identify key
features of metabolism such as growth yield, internal
distribution of resources, and network robustness. We then
used the model to predict novel strategies for the
production of precursors for bioplastics of medical and
industrial relevance. Such an integrated computational and
experimental approach can be used to study its metabolism
and to explore the potential of other industrially and
environmentally important microorganisms.
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[33], consists of 824 intracellular and 62 extracellular metabolites
connected by 877 reactions. Eight hundred twenty one (94%)
reactions have at least one assigned gene as delineated in the gene-
protein-reaction (GPR) relationships. GPR relationships are
composed of Boolean logic statements that link genes to protein
complexes and protein complexes to reactions via combinations of
AND and OR operators. An ‘AND’ operator denotes the required
presence of two or more genes for a protein to function (as in the
case of multi-protein complexes), while an ‘OR’ operator denotes
a redundant function that can be catalyzed by any of several genes
(as in the case of isozymes). Only 56 reactions, of which nine are
non-enzymatic, lack associated genes. The remaining 47 non-
gene-associated, enzymatic reactions were added in order to close
metabolic network gaps identified during the successive steps of
the reconstruction process.
Most network gaps (27) were identified during the second round
of the reconstruction and were resolved through detailed literature
mining, thereby enabling iJP815 to grow in silico on glucose in
minimal medium. The remaining gaps identified in the model
completion step (Figure 1) were mostly single missing steps in the
pathway for which there is experimental evidence of operation
(e.g., a compound is consumed but not produced, and no
alternative pathways exist). It should be noted that for some gaps,
there is more than one combination of reactions with which the
gap could be closed [34]. In cases where more than one gap
closure method was available, the decision of which to use was
made based on similarity queries to related bacteria.
The iJP815 model includes 289 reactions for which non-zero
flux values cannot be obtained under any environmental condition
while enforcing the pseudo steady-state assumption (PSSA). We
term these reactions ‘‘unconditionally blocked’’ meaning that they
are unable to function because not all connections could be made
with the information available. Three hundred sixty two
metabolites that are only involved in these reactions are classified
as ‘‘unbalanced metabolites’’. Another important subset of model
reactions is the ‘‘weakly annotated’’ set, which means that all the
genes assigned to these 57 reactions are currently annotated as
coding for ‘‘putative’’ or ‘‘family’’ proteins. The relationships
between all the subsets are shown in Table 1 and Figures 2 and 3.
The final reconstruction accounts for the function of 815 genes,
corresponding to 15% of all genes in the P. putida genome and to
65% (1253) of those currently assigned to the classes ‘Metabolism’
(K01100) and ‘Membrane Transport’ (K01310) in the Kyoto
Encyclopedia of Genes and Genomes (KEGG) orthology classi-
fication [35]. These figures are consistent with recently published
metabolic reconstructions for other prokaryotes (see Table S1).
Model Assessment and Extension through High-
Throughput Phenotyping Assays
A high-throughput BIOLOG phenotypic assay was performed
on P. putida to validate and extend the model. In this assay, P.
putida was tested for its ability to oxidize 95 carbon substrates in
minimal medium. Of these 95 substrates, P. putida oxidized 45. We
added 2 other carbon sources to the positive-oxidation group (L-
phenylalanine and L-threonine) despite a negative BIOLOG
result, since these substrates had been previously shown to be
growth substrates [16] and since we confirmed these results
experimentally (data not shown), giving altogether forty seven
compounds utilized in vivo. Forty seven out of the 95 carbon
Figure 1. Schematic diagram of the metabolic reconstruction and analysis processes. Solid lines indicate consecutive steps of the
reconstruction. Dashed lines represent information transfer. Dotted lines specify planned tasks.
doi:10.1371/journal.pcbi.1000210.g001
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pre2, enabling a
comparison of these BIOLOG data with FBA simulations of
iJP815 grown on in silico minimal medium with the respective
compound as sole carbon source (see Table 2 and Table S2).
The initial working version of the model (iJP815
pre2) was able to
simulate growth with 14 of the 47 BIOLOG-assayed compounds
as sole carbon sources. This version of the reconstruction
contained only a few transport reactions, prompting us to identify
compounds that could not be utilized in silico simply due to the lack
of a transporter. This was achieved by allowing the intracellular
pool of each compound of interest to be exchanged with
environment in silico, and by evaluating the production of biomass
in each case through FBA simulations. This approach increased
the number of utilizable substances to 34 but also produced six
false-positives (i.e., substances that support in silico growth, but
which gave a negative phenotype in the BIOLOG assay). These
included three metabolites involved in central metabolic pathways
(D-glucose 1-phosphate, D-glucose 6-phosphate and glycerol-3-
phosphate), an intermediate of the L-histidine metabolism pathway
(urocanate), an intermediate of branched amino acids biosynthesis
(2-oxobutanoate), and the storage compound glycogen. This
analysis suggests that the inability of P. putida to utilize these
compounds in vivo is likely due to the lack of appropriate transport
machinery.
The final P. putida model (iJP815) grew on 39 of the 51
compounds tested in the BIOLOG assay and that concurrently
were accounted for in the model. Of these, 33 were true positives
(compounds utilized in vivo and allowing for growth in silico). The
mode of utilization of the remaining fourteen in vivo oxidized
compounds (i.e., false negatives) could not be elucidated. The
remaining forty two compounds posed true negatives, eight of
which were accounted for in the reconstruction. Ten utilized
compounds also lack transport reactions, as nothing is known
about their translocation into the cell. Nevertheless, this
comparison of in silico growth predictions with BIOLOG substrate
utilization data indicates that the core metabolism of P. putida has
been properly reconstructed.
A note of caution when comparing the BIOLOG assays with
growth predictions is that this assay evaluates whether an organism
is able to oxidize the tested compound and yield energy from it,
which is different from growth. However, as P. putida is able to
grow on minimal medium supplemented with these compounds,
we considered the assumption to be justified.
Model-Driven Reannotation
The reconstruction process systematizes knowledge about the
metabolism of an organism, allowing the identification of errors in,
and discrepancies between, various sources of data. A major value
of a manual model-building effort is the careful revision of the
Table 1. Summary of the main characteristics of the iJP815 metabolic model.
System Parameter Subset Size
P. putida KT2440 Genome size 6.18 Mbp
Total ORFs 5446
iJP815 Reactions Total 877
Potentially active 588 (67.0%)
Unconditionally Blocked 289 (33.0%)
Well annotated 764 (87.1%)
Weakly annotated 57 (6.5%)
Non-gene-associated 56 (6.4%)
Transport 70 (8.0%)
Metabolites Total 888
Internal 824 (92.8%)
Balanced 461 (55.9%)
Unbalanced 363 (44.1%)
External 64 (7.2%)
Genes Total 815
Well annotated 701 (86.0%)
Weakly annotated 114 (14.0%)
doi:10.1371/journal.pcbi.1000210.t001
Figure 2. Schematic representation of various reaction classes
and their interdependency. The areas of the squares correspond to
the sizes of the subsets.
doi:10.1371/journal.pcbi.1000210.g002
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tered during the model building process, BLAST searches, and
gap closures. During the reconstruction of the P. putida metabolic
network, we discovered a number of genes that appear to have
been improperly annotated in biological databases (Pseudomonas
Genome Database, KEGG, NCBI). These mis-annotations arose
due to a lack of information at the time of the original annotation
or because knowledge that was available in the literature had been
overlooked in the original annotation. In a number of other cases,
the model building process has also generated new hypotheses for
gene functions. For instance, our reconstruction process identified
an unlikely gap in the L-lysine degradation pathway of P. putida.
Extensive literature search and careful reannotation has provided
considerable evidence that the genes PP0382 and PP5257,
currently annotated as ‘carbon-hydrogen hydrolase family protein’
and ‘oxidoreductase, FAD binding’ respectively, most probably
code for a ‘5-aminopentamidase’ and ‘L-pipecolate oxidase’,
respectively [36]. Another example is the propanoate degradation
pathway: In the iJP815
pre2 version this pathway was complete
except for one enzymatic activity, namely the 2-methylisocitrate
dehydratase. Analysis of the enzymes flanking this reaction showed
that all of the enzymes are encoded by genes immediately adjacent
to the ORF PP2330. Inspection of this region of the genome
revealed that PP2336 is annotated as ‘‘aconitate hydratase,
putative’’, although the flanking genes are responsible for
degradation of propanoate. Analysis of PP2330 via BLAST
revealed a homology of more than 99% over the whole length
of the protein with the 2-methylisocitrate dehydratase from other
bacteria, such as other strains of P. putida (GB-1, W619),
Burkholderia prymatum STM 815, Burkholderia multivorans ATCC
17616, Pseudomonas aeruginosa PA7, and Stenotrophomonas maltophilia
R551-3. Consequently the gene was reannotated to code for this
function and the gap in propanoate degradation pathway was thus
closed by addition of the corresponding GPR. In other cases,
discrepancies exist between various databases, as in the case of
PP5029, which is annotated in KEGG as ‘formiminoglutamase’
but in NCBI as ‘N-formylglutamate deformylase’. Analysis of
network gaps, genomic context and sequence homology provided
a strong indication that ‘N-formylglutamate deformylase’ is the
correct annotation. In many other cases the reannotation meant
changing the substrate specificity of the enzyme (which corre-
sponds to changing the last part of the EC number). These were
mainly identified by BLASTing the protein against protein
sequences of other microbes and, whenever available, cross-
checking the BLAST results against primary research publications.
The full list of reannotations suggested by the reconstruction
process is shown in Table 3.
Comparison of the Predicted and Measured Growth
Yields and the Role of Maintenance
After completing the reconstruction, we assessed whether the
model was capable of predicting the growth yield of P. putida,a
basic property of the modeled organism. In silico growth yield on
succinate was calculated by FBA and compared with in vivo growth
yield measured in continuous culture [37]. If the in silico yield were
lower than the experimental, it would indicate that the network
may lack important reactions that influence the efficiency of
conversion of carbon source into biomass constituents and/or
energy. In fact, the calculated in silico yield (0.61 gDW?gC
21) was
higher than the experimental yield (0.47 gDW?gC
21), indicating
that some of the processes reconstructed in the network might be
unrealistically efficient and/or that P. putida may be diverting
resources into other processes not accounted for in the model. This
greater efficiency of the in silico model versus in vivo growth data is
also consistent with recent studies that suggest optimal growth is
not necessarily the sole objective (function) of biochemical
networks [38,39].
The in silico growth yield is influenced not only by the structure
of the metabolic network, but also by other factors including
Table 2. Summary of the comparison with the BIOLOG
substrate utilization assay.
Compounds tested 95
Utilized compounds 47
Reconstruction version iJP815
pre2 iJP815
Tested compounds included in
the model
47 51
Utilized compounds included in
the model
33 37
Compound supply Ext Int Ext Int
True positives 14 28 23 33
True negatives 48 (14) 42 (8) 48 (14) 42 (8)
False positives 0 6 0 6
False negatives 33 (19) 20 (6) 24 (14) 14 (4)
Values in brackets indicate only those compounds that iJP815 accounts for.
doi:10.1371/journal.pcbi.1000210.t002
Figure 3. Assignment of the reactions to the particular pathways.
doi:10.1371/journal.pcbi.1000210.g003
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associated energy maintenance factors (GAM and NGAM), the
values of which represent energy costs to the cell of ‘‘living’’ and
‘‘growing’’, respectively [22]. Therefore, since both the biomass
composition and the GAM/NGAM values were taken from the E.
coli model [22,33] due to a lack of organism-specific experimental
information, we evaluated the influence of these factors on the
predicted growth yield.
First, we analyzed the effects of changes in the ratios of biomass
components on the iJP815 growth yield. These analyses (displayed
in the Text S1, section ‘‘Assessment of the influence of the biomass
composition the growth yield’’) indicated that varying any single
biomass constituent by 20% up or down has a less than 1% effect
on the growth yield of P. putida (Figure S1). These results are
consistent with results of a previous study on the sensitivity of
growth yield to biomass composition [40]. Although it is still
possible that some components of P. putida biomass are not present
in E. coli or vice versa, we conclude that the use of E. coli biomass
composition in the P. putida model is a justified assumption for the
purpose of our application and is probably not a great contributor
to the error in our predictions of growth yield.
Subsequently, the effects of changes in the GAM on the in silico
growth yield were tested (Figure S2A and S2B). It was found that if
GAM was of the same order of magnitude as the value used in the
E. coli model (13 [mmolATP?gDW
21), its influence is negligible, as
increasing or decreasing it twofold alters the growth yield by
merely 5%. A higher GAM value in P. putida than in E. coli could
contribute to the discrepancy between the experimental measure-
ments and in silico predictions, but it could not be the only factor
unless the E. coli and P. putida values differ more than twofold,
which is unlikely.
Finally, we assessed the effects of changes in the value of NGAM
on in silico growth yield. The NGAM growth dependency is
influenced by the rate of carbon source supply, and thus indirectly
by the growth rate. If the carbon intake flux is low (as in the case of
the experiments mentioned above, with a dilution rate of
0.05 h
21), the fraction of energy utilized for maintenance purposes
is high and therefore so is the influence of the NGAM value on
growth yield (Figure S2A). Under such low-carbon intake flux
conditions, a twofold increase of the NGAM value can decrease
the growth yield by about 30%. This indicates that the main cause
for the discrepancy between in vivo and in silico growth yields is that
the NGAM value is likely to be higher in P. putida than in E. coli.
Figure S2A indicates that increasing the NGAM value from 7.6 of
12 [mmolATP?gDW
21?h
21] would reduce the in silico growth yield
and lead to a better match with experimental values. Consequently
this NGAM value was used in subsequent FBA and Flux
Variability Analysis (FVA) [41] simulations.
For a high influx of carbon source (Figure S2B) the influence of
NGAM on the growth yield is low and the influence of the NGAM
and GAM values on growth yield are comparable. It should be
noted that, while FBA predicts the optimal growth yield, few
cellular systems operate at full efficiency. Bacteria tend to ‘‘waste’’
or redirect energy if it is abundant [42], leading to a lower-than-
optimal in vivo growth yield. It is also worth mentioning that
maintenance values may depend on the carbon source used [43]
and on environmental conditions [44–46].
Additionally, we computed the growth yields of P. putida on sole
sources of three other important elements—Nitrogen (N),
Phosphorous (P), and Sulfur (S)—and compared these with
published experimental data from continuous cultivations [37],
as shown in Table 4. Since biomass composition can play a role in
the efficiency of in silico usage of basic elements, this analysis can
aid in assessing how well the biomass equation, which is equivalent
to the E. coli biomass reaction, reproduces the true biomass
composition of P. putida. The yield on nitrogen differs only by 10%
between in silico and in vivo experiments, which suggests that the
associated metabolic network for nitrogen metabolism is well
characterized in the iJP815 reconstruction. The yields on
phosphorous and sulfur, however, differ by more than a factor
Table 3. List of genes reannotated during the reconstruction process.
Gene Old Annotation New Annotation Reference
PP0213 Succinate-semialdehyde dehydrogenase; EC:1.2.1.16 Glutarate-semialdehyde; dehydrogenase EC 1.2.1.20 [36]
PP0214 4-Aminobutyrate aminotransferase; EC:2.6.1.19, EC:2.6.1.22 5-Aminovalerate transaminase; EC 2.6.1.48 [36]
PP0382 Carbon-nitrogen hydrolase family protein 5-Aminopentanamidase; EC 3.5.1.30 [36]
PP0383 Tryptophan 2-monooxygenase, putative Lysine 2-monooxygenase; EC 1.13.12.2 [36]
PP2336 Aconitate hydratase, putative; EC:4.2.1.3 2-Methylisocitrate dehydratase; EC 4.2.1.99
a
PP2432 Oxygen-insensitive NAD(P)H nitroreductase; EC:1.-.-.- 6,7-Dihydropteridine reductase; EC 1.5.1.34
a
PP3591 Malate dehydrogenase, putative; EC:1.1.1.37 D
1-Piperideine-2-carboxylate reductase; EC 1.5.1.21 [36]
PP4066 Enoyl-CoA hydratase, putative; EC:4.2.1.17 Methylglutaconyl-CoA hydratase; EC 4.2.1.18 [88]
PP4065 3-Methylcrotonyl-CoA carboxylase, beta subunit, putative
EC:6.4.1.3
Methylcrotonoyl-CoA carboxylase; EC 6.4.1.4 [88]
PP4067 AcCoA carboxylase, biotin carboxylase, putative; EC:6.4.1.3 Methylcrotonoyl-CoA carboxylase; EC 6.4.1.4 [88]
PP4223 Diaminobutyrate-2-oxoglutarate transaminase; EC:2.6.1.76 Putrescine aminotransferase; EC 2.6.1.82
a
PP4481 Acetylornithine aminotransferase; EC:2.6.1.11 Succinylornithine transaminase; EC 2.6.1.81
a
PP5029 Formiminoglutamase; EC:3.5.3.8 N-Formylglutamate deformylase; EC 3.5.1.68
a
PP5036 Atrazine chlorohydrolase N-Formylglutamate deformylase; EC 3.5.1.68
a
PP5257 Oxidoreductase, FAD-binding L-Pipecolate oxidase; EC 1.5.3.7 [36]
PP5258 Aldehyde dehydrogenase family protein; EC:1.2.1.3 L-Aminoadipate-semialdehyde dehydrogenase; EC 1.2.1.31 [36]
aAnalysis of the sequence homology and genomic context information.
doi:10.1371/journal.pcbi.1000210.t003
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there may be significant differences between the biomass
requirements and the metabolic networks of P. putida and E. coli
for these components. The differences in yields, however, may be
also caused by the change of the in vivo biomass composition,
which decreases the fraction of compounds containing the limited
element, when compared to the biomass composition while the
bacterium is grown under carbon-limitation. Such changes were
observed experimentally in P. putida for nitrogen and phosphate
limitations [47]. Thus, the biomass composition of P. putida needs
to be determined precisely in the future. However, for the purpose
of this work and since the global effect of the biomass composition
on the outcome of the simulations is negligible (as shown above),
we considered the use of the original biomass equation to be
justified.
Analysis of Blocked Reactions: The Quest for
Completeness
As described above, iJP815 contains 289 unconditionally (i.e.,
not dependent on external sources) blocked reactions (that is,
reactions unable to function because not all connections are
made), corresponding to 33% of the metabolic network. In
previously published genome-scale metabolic reconstructions, the
fraction of blocked reactions varies between 10 and 70 percent
[48]. Blocked reactions occur in reconstructions mostly due to
knowledge gaps in the metabolic pathways. Accordingly, the
blocked-reactions set can be divided into two major groups; (1)
reactions with no connection to the set of non-blocked reactions,
and (2) reactions that are either directly or indirectly connected to
the operating core of the P. putida model. The first group of
reactions includes members of incomplete pathways that, with
increasing knowledge and further model refinement, will gradually
become connected to the core. This subset comprises 108
reactions (35% of blocked reaction set). The second group of
reactions comprises also members of incomplete pathways, but
many of them belong to pathways that are complete but that lack a
transport reaction for the initial or final compound. Examples of
pathways lacking a transporter are the degradation of fatty acids
and of propanoate.
In addition, there could exist compounds whose production is
required only in certain environmental conditions, e.g., under
solvent stress, and as such are not included in generic biomass
equation. Pathways synthesizing compounds that are not included
in the biomass equation but that likely are conditionally required
include the synthesis of thiamine, various porphyrins and
terpenoids. In this case, reactions involved exclusively in the
production of such compounds would be blocked if no alternative
outlets exist for those pathways. Allowing a non-zero flux through
these reactions would require inclusion into biomass of the
conditional biomass constituents, which in turn would require
having various biomass equations for various conditions. This level
of detail, however, is beyond the scope of our initial metabolic
reconstruction and investigation.
The high number of blocked reactions in iJP815 clearly
indicates that there are still vast knowledge deficits in the model
and, thus, in the underlying biochemical and genomic informa-
tion. Since a genome-scale metabolic model seeks to incorporate
all current knowledge of an organism’s metabolism, these reactions
are integral elements of the metabolic reconstruction and of the
modeling scaffold, even if they are not able to directly participate
in steady state flux studies. Therefore, the inclusion of these
reactions in the model provides a framework to pin-point
knowledge gaps, to include novel information as it becomes
available and to subsequently study their embedding and function
in the metabolic wiring of the cell.
How P. putida Allocates Its Resources: Evaluating the
Prediction of Internal Flux Distributions
The assessment performed as described above by means of
high-throughput phenotyping assays, growth experiments and
continuous cultivations, has shown that the model is coherent and
that it captures the major metabolic features of P. putida.W e
subsequently used the model to probe the network and to ascertain
the distribution of internal fluxes and properties such as network
flexibility and redundancy of particular reactions. To this end, we
predicted the distribution of reaction fluxes throughout the central
pathways of carbon metabolism by flux variability analysis (FVA),
and compared the simulations to internal fluxes computed from
experimentally obtained
13C data in P. putida [49,50].
Optimal FVA
Genome-scale metabolic networks are, in general, algebraically
underdetermined [41]. As a consequence, the optimal growth rate
can often be attained through flux distributions different than the
single optimal solution predicted by FBA simulations. Therefore
we used flux variability analysis (FVA) to explore the network, as
this method provides the intervals inside which the flux can vary
without influencing the value of the growth yield (if the flux of the
reaction cannot vary then the range is limited to a single value)
[41]. The results of the simulations are given in Figure 4. As
isotopic (
13C) measurements are not able to distinguish which
glucose uptake route is being used by P. putida, all the fluxes in the
13C experiment and in the FVA simulations were computed
assuming that glucose is taken up directly into the cell. For the
precise description of the network models used in this comparison
(i.e., FBA/FVA vs.
13C-Flux analysis) see Text S1 and Text S2
(sections ‘‘Comparison of FVA analyses with
13C flux measure-
ment data’’).
Figure 4 shows that the predictions (in red) generally agree well
with the measurements (in green) throughout the network, as most
of the
13C values fall within the FVA intervals, where intervals
were predicted, or both values are close to each other (in absolute
values), when a single value was predicted. As P. putida lacks
phosphofructokinase, glucose can be converted to pyruvate (the
entry metabolite of TCA cycle) via the pentose phosphate (PP) or
the Entner-Doudoroff (ED) pathways. The ED pathway is
energetically more efficient and the
13C measurements indicate
that KT2440 uses it preferentially over the PP pathway.
Therefore, the FVA yields locally single flux values rather than
intervals, which reflects the relative rigidity of this part of the
network. In contrast, the energy generating part of the central
metabolic network (the TCA cycle and its vicinity) exhibits greater
flexibility, as illustrated by the broad flux intervals. Firstly, the
conversion of phosphoenylpyruvate into pyruvate can proceed
Table 4. Comparison of the in silico predicted growth yields
(in gDW?gElement
21) with experimental continuous culture
data.
Limiting Element Yield – Experimental Yield – Model
C 0.47 0.61
N 5.74 6.67
P 84.95 34.92
S 268.75 130.18
doi:10.1371/journal.pcbi.1000210.t004
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to use the direct route (the
13C-model assumes, in fact, only the
direct route; see Text S1, section ‘‘Comparison of FVA analyses
with
13C flux measurement data’’). Secondly, the conversion of
malate to oxaloacetate may also occur directly or via pyruvate.
The
13C flux measurements indicate that the bacterium uses the
indirect route in addition to the direct one although, according to
the FVA, the indirect route is energetically less efficient.
Interestingly, our model suggests also that the glyoxylate shunt
could be used interchangeably with full TCA-cycle without any
penalty on growth yield. However, as the glyoxylate shunt is
inactivated in many bacterial species via catabolite repression
upon glucose growth [51], it is possible that this alternative is not
used in P. putida.
Figure 4. Comparison of FVA calculations with
13C experimental flux data. The explanation of color codes is given in the figure. ‘‘0*’’ means
that the reaction is not included in the particular metabolic network; double-headed arrows depict reversible reactions, the bigger head shows
direction of the positive flux.
doi:10.1371/journal.pcbi.1000210.g004
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Measurements
Despite the general agreement between insilicopredictions and
13C
measurements, there still exist a number of discrepancies. For
instance, the
13C-experiments suggest that the bacterium utilizes the
portion of glycolysis between triose-3-phosphate and D-fructose-6-
phosphate in the gluconeogenic direction, which is not energetically
optimal and as such is not captured in standard FBA (or FVA)
simulations. This illustrates one of the possible pitfalls of FBA, which
per definition assumes perfect optimality despite the fact that
microorganisms mightnot necessarily allocate their resources towards
the optimization function assumed in analysis, and in somecases may
not operate optimally at all [52,53]. Another group of differences
concentrates around the pentose phosphate pathway (PPP), although
these are relatively minor and are likely due to differences in the
quantities of sugar diverted toward biomass in the
13Cm o d e lv s .
iJP815. A third group of differences revolves around pyruvate and
oxaloacetate, whereby the in vivo conversion of malate to oxaloacetate
shuttles through a pyruvate intermediate rather than directly
converting between the two. The last area where discrepancies exist
between in silico and
13C data is in the TCA cycle, around which the
fluxislowerinFVAsimulationsthanintheexperiment.Thissuggests
that the in silico energetic requirements for growth (maintenance
values) are still too low when compared to in vivo ones, as the main
purpose of the TCA cycle is energy production.
Suboptimal FVA
To investigate further these differences, we carried out a
suboptimal FVA (Figure 4, blue values), allowing the production of
biomass to range between 90 and 100% of its maximum value. In
this suboptimal FVA experiment, the
13C-derived fluxes fall
between FVA intervals for every flux value in the
13C network. To
filter out artifacts, we re-did all FVA computations using the
structure of the network used in the
13C-experiment and found no
major differences (see Figure S3). We also assessed the influence of
the biomass composition on the distribution of internal fluxes and
network structure and found that this was negligible on both
accounts (see Text S2, section ‘‘Evaluation of biomass equation
composition on the outcome of FBA/FVA simulations’’ and
Figure S4). The results show that, in principle, the bacterium can
use all the alternatives described above and that the penalty on the
growth yield is minimal. While this analysis validates the FVA
simulation results, the wide breadth of the intervals (i.e., the mean
ratio of interval width to mean interval value exceeds three),
suggests that the (mathematical) under-determination of central
metabolism can be quite high, and indicates that there exist
multiple sub-optimal solutions across the network and that is thus
difficult to predict exact internal flux and to ‘‘pin-point’’ a
particular solution. These results reflect the essence of constraint-
based modeling and FBA, which provide only a space of possible
flux distributions and not exact values. Therefore, deductions from
results of FBA simulations have to be made with great care. This
underscores the notion that constraint based modeling should be
seen more as navigation framework to probe and explore networks
rather than as an exact predictive tool of cellular metabolism.
Gauging the Robustness of the Network
Essentiality of genes and reactions. To assess the
robustness of the metabolic network to genetic perturbations
(e.g., knock-out mutations), we carried out an in-silico analysis of
the essentiality of single genes and reactions, which enabled us to
identify the most fragile nodes of the iJP815 network. Reaction
essentiality simulations were performed by systematically removing
each reaction from the network and by assessing the ability of the
model to produce biomass in silico via FBA in minimal medium
with a sole carbon source (glucose and acetate). Gene essentiality
was assessed by: (i) identifying for each gene the operability of the
reaction(s) dependent on this gene, (ii) removing from the network
the reactions rendered inoperative by the deletion of that
particular gene, and (iii) determining the ability of the model to
produce biomass in the same manner as for the reaction
essentiality tests. Additionally, we estimated for both carbon
sources the smallest possible set of reactions able to sustain in silico
growth, in order to estimate the number of reactions necessary for
biomass synthesis in minimal medium (minimal set). This set
encompasses both all reactions that are essential (including those
essential regardless of the medium and those ‘conditionally
essential’) and the minimal number of non-essential reactions
that, together, are able to provide in silico growth (see Figure 5).
These conditionally essential reactions can be used as a reference
for identifying sections of metabolism for which alternative
pathways exist. For both glucose and acetate, the minimal sets
encompassed approximately 315 reactions (Table S5). This
estimate is consistent with values obtained for other bacteria [54].
The sets of essential reactions consist of 259 and 274 reactions
for glucose and acetate conditions respectively, constituting 82 and
86 percent of the minimal set. These numbers indicate that most of
the crucial metabolic routes are not duplicated at the level of
metabolic network structure. The set of essential reactions under
glucose growth is a subset of that under acetate, suggesting that the
growth on glucose is more resistant to perturbations (as the smaller
number of reactions mean less fragility points in the network). The
reactions belonging exclusively to the acetate minimal set are
mostly members of glyconeogenic pathway, with ATP synthase,
the reactions constituting the glyoxylate shunt, and acetate
transport reactions being the exceptions. The inessentiality of
ATP synthase under glucose and essentiality of the glyoxylate
shunt under acetate conditions are not surprising and similar
effects have been reported in E. coli [55–57].
The reactions belonging to the non-essential part of the minimal
set are mostly members of central metabolic pathways (PPP, TCA
cycle, and Pyruvate metabolism), which emphasizes the impor-
tance of these pathways for the operation of the metabolism and is
in agreement with observations made in other bacteria [58].
Figure 5. Interdependency between the metabolic network,
the minimal set and the set of essential reactions. The set sizes
are given for glucose growth conditions.
doi:10.1371/journal.pcbi.1000210.g005
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also be provided at the genetic level through genes coding for
isozymes. Data on gene and reaction essentiality provide insights
into this phenomenon. We utilized FBA to generate a list of in silico
essential gene predictions, including 153 and 159 genes under
minimal glucose and acetate growth respectively, in order to
determine how gene/pathway redundancy affects network
robustness. These values may seem low when compared to the
size of the predicted essential reactions sets (259 and 274 reactions
for glucose and acetate growth, respectively). However, it must first
be noted that each essential reaction set contains about 25 (26 and
27 for the glucose and acetate essential set, respectively) non gene-
associated reactions, and that elucidating the genes catalyzing these
reactionswouldincreasesubstantiallythenumberofinsilicoessential
genes. Further, approximately 20% of each minimal set (78 and 84
genes under glucose and acetate conditions, respectively) consists of
essential reactions that can be catalyzed by two or more isozymes
and thus are essential at the metabolic network level but not at the
genetic level. In contrast to non-essential reactions in the minimal
set,thesereactionsessentialatthe metabolicnetworklevelbutnotat
the genetic level are not clustered in particular metabolic pathways
but are rather spread throughout the entire metabolic network.
Altogether, these results indicate that for about 40% of the reactions
required to produce biomass, there are alternative at either the
genetic or the metabolic network level.
This analysis highlights the limitations of possible interventions
aimed at reshaping the flux distributions, because these can be
applied only to reactions that are not essential (since the
inactivation of an essential reaction yields a lethal phenotype).
Identification of reactions catalyzed by multiple enzymes shows
which reactions may be best avoided when planning mutational
strategies as their inactivation may pose additional technical
problems, by requiring production of multiple knock-outs.
Flexibility of flux distributions. To further investigate
these conclusions, we determined the flexibility of fluxes over
particular reactions as a measure of metabolic network flexibility
during biomass production. We found that the variability of fluxes
is similar under either glucose or acetate growth, but that acetate
growth instills a slightly higher rigidity to the metabolic network (as
observed above). We observed also that the flux of more than a
half of the reactions can vary to some degree without influencing
biomass output. We next analyzed the pathway-distribution of
reactions exhibiting variable flux, and found that biosynthetic
pathways are in general more rigid (i.e., the fraction of reactions
with flexible flux is relatively lower) than other pathways. This
rigidity might reflect the essentiality of these pathways modules for
the survival of the cell (See sections ‘‘Analysis of flexibility of the
flux over particular reactions’’ in the Text S1 and Text S2, Figure
S5, Table S3 and Table S5). A further measure to ascertain
network flexibility was the assessment of pairwise couplings
between the reactions via Flux Coupling Finder (see Text S1
and Text S2, sections ‘‘Flux Coupling Finder’’ and Figure S6).
This analysis indicated that for 90% of the reactions that are
unblocked in a given condition, at least one other reaction exists
whose flux is proportionally coupled to the flux of the first
reaction, and therefore that the great majority of reactions can be
inactivated through inactivation of some other reaction. This
analysis is helpful in optimizing mutational strategies as it pin-
points alternative mutations that exhibit equivalent outcomes.
Prediction of Auxotrophic Mutations and Model
Refinement
Assessment of network models through comparison of in silico
growth-phenotypes with the growth of knock-out strains is a
powerful way to validate predictions. This has been done in a
number of studies for which knock-out mutant libraries were
available [59,60]. As there is currently no mutant library for P.
putida, we tested gene knock-out predictions with a set of P. putida
auxotrophic mutant strains created in our laboratory that are
incapable of growth on minimal medium with acetate as the sole
carbon source. First we compared whether the corresponding in
silico mutants followed the same behavior (lack of growth on
minimal medium with acetate, where zero biomass flux during FBA
corresponded to a no-growth phenotype). This comparison was
performed only for strains whose knocked-out gene is included in
iJP815. Thirty-eight out of the 51 strains tested did not grow in silico
(Table S4). Of the remaining 13 false positives (i.e., those growing in
silico but not in vivo), four (PP1470, PP1471, PP4679, and PP4680)
are mutated in genes considered non-essential in silico due to
‘‘weakly annotated’’ gene putatively encoding redundant isozymes.
In the case of PP5185 (coding for N-acetylglutamate synthase), its
essentiality is removed by PP1346 (coding for bifunctional ornithine
acetyltransferase/N-acetylglutamate synthase protein), which is not
only an isozyme of PP5185 (the N-acetylglutamate synthase
function) but which also catalyses a reaction (ornithine acetyltrans-
ferase) that produces N-acetyl-L-glutamate (the product of N-
acetylglutamate synthase) and thus renders the activity of PP5185
redundant. It appears either that this is a mis-annotation or that the
enzyme is utilized only under different conditions.
In addition, PP0897 (fumC) seems to have two paralogues
(PP0944, PP1755) coding for isoenzymes of fumarate hydratase,
but since the mutant in PP0897 does not grow auxotrophically,
they are either non functional or mis-annotated. The enzyme
complex that is composed of proteins expressed from the genes
knocked-out in the two false positives PP4188 and PP 4189
catalyzes the decarboxylation of a-ketoglutarate to succinyl-CoA
in the TCA cycle, concurrently producing succinyl-CoA for
anabolic purposes. In the model, this functionality is not needed as
this part of the TCA cycle can be circumvented by the glyoxylate
shunt, whereas succinyl-CoA can be produced by reverse
operation of succinate-CoA ligase. Restricting this reaction to be
irreversible renders both genes essential. This altogether suggests
that either the succinate-CoA ligase is irreversible or the glyoxylate
shunt is inactive. The latter solution is, however, impossible, due to
the essentiality of the glyoxylate shunt upon growth on acetate.
The false positive PP4782 is involved in thiamine biosynthesis.
This cofactor is not included in the biomass, which is why the gene
is not in silico essential. This suggests thus that the in-silico P. putida
biomass reaction should be enriched with this cofactor. The
remaining false positives (PP1768, PP4909, PP5155) are involved
in the serine biosynthesis pathway. We found experimentally that
mutants in these genes can grow on acetate if the medium also
contains L-serine. These genes can be rendered in silico essential by
setting glycine hydroxymethyltransferase to operate only unidi-
rectionally from L-serine to glycine. The operation of this enzyme,
however, is required for growth of the bacterium on glycine, which
is possible; though very slow (results not shown). One of these
genes (PP5155) has also a weakly annotated isozyme (PP2335). We
found out as well that several of the mutants (PP1612, PP4188-9,
PP4191-4) grow in silico on glucose, which we confirmed
experimentally (results not shown). Altogether, these experimental
results assisted us in improving the accuracy of the model.
Albeit limited to a relatively small mutant set, this analysis shows
that while constraint-based models are not always able to predict
exact flux values, they are very useful in the identification of
essential reactions and, through the GPRs, the genes responsible
for their catalysis. This enables identification of vulnerable points
in the metabolic network.
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Polyhydroxyalkanoates from Nonalkanoates
To illustrate the utility of a genome-scale model for metabolic
engineering, we used iJP815 to predict possible improvements to an
industrially relevant process; namely, the production of polyhy-
droxyalkanoates (PHAs) from non-alkanoic substrates for biomed-
ical purposes [61–63]. As the production of PHAs uses resources
that would be otherwise funneled towards growth, increasing in silico
PHA production would decrease the growth. Consequently, in
classic optimization-based approaches (e.g., FBA), no PHA
production would be predicted while optimizing for growth yield.
The aim was thus to increase the available pool of the main
precursor of PHAs—Acetyl Coenzyme A (AcCoA). This approach
was based on the observation that inactivation of isocitrate lyase
(ICL) enhances the production of PHAs in P. putida due to increased
availability of AcCoA that is not consumed by ICL [64]. We
therefore searched for other possible intervention points (mutations)
in the metabolic network that could lead to the accumulation of
AcCoA. This analysis was performed through application of a
modified OptKnock approach [28], which allowed for parallel
prediction of mutations and carbon source(s) that together provide
the highest production of the compound of interest.
Two main methods were employed to model a cellular pooling of
AcCoA. The first was the maximization of AcCoA production by
pyruvate dehydrogenase(PDH).Inthe second, anauxiliaryreaction
was introduced that consumed AcCoA (concurrently producing
CoA, to avoid cofactor cycling artifacts) and that would represent
the pooling of AcCoA (Figure 6A and 6B, insets). It is noteworthy
that the value of ‘AcCoA production’ predicted by the first method
includes AcCoA that is then consumed in other reactions (some of
which will lead towards biomass production for instance), whereas
the value of ‘AcCoA pooling’ predicted by the second method
includes only AcCoA that is taken completely out of the system, and
therefore made available for PHA production but unusable for
growth or other purposes. Therefore, only with the first method
(AcCoA production) can AcCoA fluxes and growth rates be
compared directly with the wild-type AcCoA flux and growth rate,
as the second method (AcCoA pooling) will display lower values for
AcCoA fluxes and growth rates but will avoid ‘double counting’
AcCoA flux that is shuttled towards growth, and therefore is not
available for PHA production (see plots in Figure 6A and 6B).
To create the in silico mutants, we allowed the OptKnock
procedure to block a maximum of two reactions, which
corresponds, experimentally, to the creation of a double mutant.
To avoid lethal in silico strains, the minimal growth yield was
limited to a value ranging between 0.83 and 6.67 gDW?molC
21,
corresponding to about 5 and 40 percent of maximum growth
yield, respectively.
Six mutational strategies suggested by this approach are
presented in Table 5. The first three were generated by the
AcCoA production method, and the last three were generated by
the AcCoA pooling method. The results provide a range of options
for possibly increasing AcCoA production, some of which
constrain growth more than others (see Figure 6A and 6B).
One promising hypothesis (strategy 2) generated by the AcCoA
production method predicted that a double-mutant devoid of 6-
phosphogluconolactonase (pgl/PP1023) and periplasmatic glucose
dehydrogenase (gcd/PP1444), would produce 29% more AcCoA
than the wild type growing on glucose as a carbon source
(Figure 6A). As we are currently still in the process of generating
this mutant, we were not yet able to test the prediction. Another
promising hypothesis (strategy 1) included knocking-out triose
phosphate isomerase (tpiA/PP4715). As the mutant for tpiA was
generated in this work, we tested whether it is able to grow on the
predicted carbon source (D-fructose), but the observed growth was
very weak (only very small colonies grew on agar plates after three
days). This suggests that growth might be too inhibited by this
strategy for it to be of great use.
One strategy suggested by the AcCoA pooling method (strategy
4) called for knocking out 2-methylcitrate dehydratase (prpD/
PP2338) and citrate synthase (gltA/PP4194), and supplying P. putida
with valine. Using this strategy, AcCoA pooling could theoretically
reach 21.9 mmol?gDW
21?h
21, but at a severe expense in bacterial
growth (Figure 6B). The other strategies suggested by the AcCoA
pooling method highlight a somewhat linear tradeoff between
growth and AcCoA pooling, which could be investigated experi-
mentally to determine how much growth disruption is acceptable in
a bioengineered production strain of P. putida (Figure 6B).
These strategies illustrate the possible approaches to optimizing
production of a non-growth associated compound, and highlight
the need for further experimental work to assess the performance
of this approach.
Discussion
A primary value of genome-scale metabolic models is their
ability to provide a holistic view of metabolism allowing, for
Figure 6. Mutational strategies for increased PHA production.
This figure highlights 6 strategies suggested by the modified optknock
approach for increased production of AcCoA, a precursor for
polyhydroxyalkanoates. (A) AcCoA production ranges vs. growth yield
of in silico strains developed using the ‘AcCoA production’ strategy. (B)
AcCoA pooling versus growth yield of in silico strains developed using
the ‘AcCoA pooling’ strategy.
doi:10.1371/journal.pcbi.1000210.g006
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species existing far apart in the metabolic network [20]. Once
experimentally validated, these models can be used to characterize
metabolic resource allocation, to generate experimentally testable
predictions of cell phenotype, to elucidate metabolic network
evolution scenarios, and to design experiments that most
effectively reveal genotype-phenotype relationships. Furthermore,
owing to their genome-wide scale, these models enable systematic
assessment of how perturbations in the metabolic network affect
the organism as a whole, such as in determining lethality of
mutations or predicting the effects of nutrient limitations. Since
these multiple and intertwined relationships are not immediately
obvious without genome-scale analysis, they would not be found
during investigation of small, isolated circuits or genes as is typical
in a traditional reductionist approach [65,66].
We present here a genome-scale reconstruction and constraint-
based model of the P. putida strain KT2440, accounting for 815
genes whose products correspond to 877 reactions and connect
886 metabolites. The manually curated reconstruction was based
on the most up-to-date annotation of the bacterium, the content of
various biological databases, primary research publications and
specifically designed functional genomics experiments. New or
refined annotations for many genes were suggested during the
reconstruction process. The model was validated with a series of
experimental sets, including continuous culture data, BIOLOG
substrate utilization assays,
13C flux measurements and a set of
specifically-generated mutant strains. FBA and FVA were used to
ascertain the distribution of resources in KT2440, to systematically
assess gene and reaction essentiality and to gauge the robustness of
the metabolic network. Hence, this work represents one of the
most thorough sets of analyses thus far performed for an organism
by means of constraint-based modeling, providing thereby a solid
genome-scale framework for the exploration of the metabolism of
this fascinating and versatile bacterium. However, since this
modeling endeavor relies upon a number of approximations, the
limits, potential and applicability of the analysis must be clearly
identified and defined. We address these points below.
Altogether, our results and analyses show that the model
accurately captures a substantial fraction of the metabolic
functions of P. putida KT2440. Therefore, the model was used to
generate hypotheses on constraining and redirecting fluxes
towards the improvement of production of polyhydroxyalkanoates,
which are precursors for industrially and medically important
bioplastics. This is, to our knowledge, the first reported application
of constraint-based modeling to direct and improve the yield of a
compound of which the production is not directly coupled to the
growth of the organism. This opens up novel areas of application
for the constraint-based approach. Our approach, based on the
OptKnock algorithm, allows for both prediction of mutants with
desirable properties and identification of conditions that support
the expression of these properties.
Notwithstanding the generally good agreement between exper-
imental results and simulations of our model, several of the
discrepancies encountered reflect pitfalls inherent to constraint-
based modeling that go beyond the scope of our study:
Firstly, the high number of blocked reactions and the
mismatches with the BIOLOG data show that there are still
many areas of the metabolism that require thorough exploration.
The genes encoding transport-related are particularly relevant, as
for most of them, neither the translocated compound nor the
mechanism of translocation is known. Furthermore, it should be
highlighted that the genome still has 1635 genes annotated as
‘‘hypothetical’’ or ‘‘conserved hypothetical’’, more than 800 genes
annotated as putative, and over 800 for which the functional
Table 5. Summary of the characteristics of the in silico strains generated in the procedure of optimization of the PHA production.
Strain Blocked Enzymatic Activity Loci To Be Blocked Carbon Source(s)
AcCoA Production
[mmol gDW
21?h
21]
Growth Yield
[gDW?molC
21]
Min Max Limit Sim
WT WT WT L-Serine 11.47 22.26 0.83 11.16
1 Triose-phosphate isomerase PP4715 D-Fructose 7.7 29.74 0.83 3.5
6-Phosphoglucono lactonase PP1023
2 Glucose dehydrogenase
(membrane)
PP1444 D-Glucose 7.05 28.51 0.83 4.17
6-Phosphoglucono lactonase PP1023
3 Isocitrate dehydrogenase PP4011 or PP4012 L-Serine 22.41 23.01 6.66 10.67
Formate dehydrogenase PP0490 or PP0491
PP2183 or PP2184 or PP2185 or PP2186
4 Citrate synthase PP4194 L-Valine 21.85 0.83 1.00
2-Methylcitrate dehydratase PP2338
5 Glycine hydroxymethyl transferase PP0322 L-Leucine, L-lysine, L-
phenyl-alanine
16.75 3.33 4.00
PP0671
Citrate synthase PP4194
6 Glycine hydroxymethyl transferase PP0322 L-Leucine, L-isoleucine 9.35 6.66 9.33
PP0671
Citrate synthase PP4194
doi:10.1371/journal.pcbi.1000210.t005
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It is thus likely that a fraction of the hypothetical and non-
specifically annotated genes in the current P. putida annotation are
responsible for unknown metabolic or transport processes, or that
some might code for proteins that add redundancy to known
pathways. This observation is common to all genomes sequenced
so far and illustrates a major hurdle in the model building process
(and hence, its usefulness) that can be overcome only through
extensive studies in functional genomics.
Secondly, although we carefully constrained the in silico flux
space through FBA and FVA and obtained distribution spaces
roughly consistent with those experimentally determined via
13C-
flux analysis, these approaches are inherently limited as they
assume growth as a sole metabolic objective and ignore any effects
not explicitly represented in a constraint-based metabolic model. It
has been shown that FBA using objective functions other than
growth can improve predictive accuracy under certain conditions
[53]. Kinetic limitations also may play a very important role in
determining the extent to which a particular reaction or pathway
is used. Teusink et al. [52] showed that in the case of L. plantarum
these factors may lead to false predictions.
Thirdly, the reconstruction includes causal relationships between
genes and reactions via gene-protein-relationships (GPRs) but it
lacks explicit information regarding gene regulation. The regulation
of gene expression causes that there are many genes in the cell that
are expressed only under certain growth conditions. Therefore, the
in silico flux space is generally larger than the true in vivo flux space of
the metabolic network. This, in turn, may influence the robustness
of the metabolic network and the essentiality of some reactions and
genes. The lack of regulatory information and of the genetic
interactions involved is likely to be one of the causes for faulty
predictions of the viability of mutant strains. Adding this
information will be an important step in the further development
and improvement of the accuracy of the reconstruction.
Fourthly, although our analyses indicated that growth yield is
relatively insensitive to changes in biomass composition, these
analyses also suggest that factors other than the structure of the
metabolic network play an important role in defining the
relationship between the growth yield and environmental
conditions. The prediction of the exact growth yield requires the
precise measurement of maintenance values, which may vary
substantially from one condition to the other [44–46]. As the
maintenance accounts for 10–30% of the total carbon source
provided in unstressed conditions, this may set a limit to the
accuracy of the growth yield predictions.
To enhance the usefulness and predictiveness of the model,
several avenues could be followed in the future. Firstly, additional
constraints can be overlaid on the network to reduce the space of
possibilities and increase the accuracy of predictions. In addition to
specific knowledge of particular enzymatic or transport processes,
such constraints are best based on high-throughput experimental
evidence such as transcriptomic and proteomic data, which are
instrumental in expanding genotype-phenotype relationships in
the context of genome-scale metabolic models [67]. Microarray
experiments have guided the discovery of metabolic regulons, and
usage of microarray and proteomic data to constrain metabolic
models has improved model accuracy for other systems [23].
Secondly, P. putida provides a good opportunity for incorporating
kinetic information into a genome-scale model as there are various
kinetic models available and under development for small circuits
in P. putida [68–71]. Incorporating data from these models into the
genome-scale reconstruction would provide insights into the
relationships of isolated metabolic subsystems within the global
metabolism. This synthesis would also improve the flux predictions
of the global model, particularly in areas where current FBA-based
predictions methods fail due to their inherent limitations.
Experimental validation of a genome-scale model is an iterative
process that is performed continuously as a model is refined and
improved through novel information and validation rounds. In this
work, we have globally validated iJP815 as well as specific parts
thereof by using both up-to-date publicly available data and data
generated in our lab, but there will be always parts of the model
that include blocked reactions and pathways that will require
further, specific validation. As more knowledge becomes available
from the joint efforts of the large P. putida community (e.g., http://
www.psysmo.org), focus will be put on these low-knowledge areas
for future experimental endeavors. We anticipate that this model
will be of valuable assistance to those efforts.
The metabolic reconstruction, the subsequent mathematical
computation and the experimental validation reported here provide
a sound framework to explore the metabolic capabilities of this
versatile bacterium, thereby yielding valuable insights into the
genotype-phenotype relationships governing its metabolism and
contributing to our ability to exploit the biotechnological potential
of pseudomonads. By providing the means to examine all aspects of
metabolism, an iterative modeling process can generate logical
hypotheses and identify conditions (such as regulatory events or
conditional expression of cellular functions) that would reconcile
disagreements between experimental observations and simulation
results. Through a detailed in silico analysis of polyhydroxyalkanoate
production, we show how central metabolic precursors of a
compound of interest not directly coupled to the organism’s growth
function might be increased via modification of global flux patterns.
Furthermore, as the species Pseudomonas putida encompasses strains
with a wide range of metabolic features and numerous isolates with
unique phenotypes, the reconstruction presented provides a basic
scaffold upon which future models of other P. putida strains can be
built with the addition or subtraction of strain-specific metabolic
pathways. Due to its applicability across the numerous P. putida
strains iJP815 provides a sound basis for many future studies
towards the elucidation of habitat-specific features, bioremediation
applications and metabolic engineering strategies with members of
this ubiquitous, metabolically versatile and fascinating genus.
Materials and Methods
Constraint-Based Models
The P. putida model we present was built using a constraint-
based (CB) approach. A constraint-based model consists of a
genome wide stoichiometric reconstruction of metabolism and a
set of constraints on the fluxes of reactions in the system
[19,20,24]. The reconstruction represents stoichiometry of the
set of all reactions known to act in metabolism of the organism,
which can be determined in large part from genomic data since
most cellular reactions are catalyzed by enzymes. Thus the model
does not require any knowledge regarding the kinetics of the
reactions, and the requisite thermodynamic knowledge is limited
to the directionality of reactions.
In addition to the reactions, the model includes a set of genes
tied via Boolean logic to reactions that their protein products
catalyze, which allows for accurate discrimination of the effects of
genetic perturbations such as knockouts [33,72]. These Boolean
rules together form the gene-protein-reaction relationships (GPRs)
of the metabolic reconstruction [33].
The second part of the CB-model, namely the constraints,
constitutes a set of rules that narrow down the interval within
which the flux of particular reaction must lie. These constraints
rest upon physico-biological knowledge. One of them, the
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mentioned above. Another constraint that is widely applied in
biological systems is the Pseudo-Steady-State Assumption (PSSA)
[73], which states that a concentration of a chemical compound
stays constant over the simulated time frame. The reactants to
which this constraint is applied are usually called internal
compounds, and in biological models correspond to the chemical
substances located inside the cell or its compartments. Remaining
substances, external compounds, correspond to species that can be
taken up or secreted and thus exchanged with the environment.
Other types of constraints are top and bottom limits that
correspond to catalytic capabilities of the enzymes. More detailed
description of constraint based modeling approach can be found in
[74] and the Text S1, section ‘‘Constraint based models—
mathematical explanation’’.
Analysis Methods
Flux balanceanalysis. Flux balanceanalysis(FBA)is aprimary
method for analysis of constraint-based models. Generally, a
constraint based model of metabolism represents an
underdetermined system, i.e., one in which a range of flux
distributions are mathematically possible. FBA narrows the flux
possibilities by determining a point in closed flux space that
maximizes a certain linear combination of fluxes. [75]. FBA poses
a linear programming (LP) problem and thus a global maximum
always exists, provided that the problem is feasible (i.e., there exists at
leastonecombinationoffluxeswhichfulfillsalltheconstraints).Using
the matrix notation the FBA problem can be stated as following:
maximize : cT : v
subject to : Si : v ~ 0
vmin ƒ v ƒ vmax,
where S is the stoichiometric matrix containing reaction
stoichiometry information, v is a vector of all reaction fluxes in the
system, vmin and vmax represent minimum and maximum constraints
on reaction fluxes, respectively, and c
T is a vector containing
coefficients for each flux that is to be maximized (for more detail on
FBA, refer to [76]).
FBA optimization yields an optimal value for the objective along
with a flux value for every reaction belonging to the metabolic
network. Commonly, FBA is used to predict maximal growth or
metabolite production yields. Cell growth is simulated by the flux
over a special ‘Biomass’ reaction that consumes precursors of
cellular components (amino acids, lipids, dNTPs, NTPs, cofactors)
and produces a virtual unit of cell biomass. Maximization of this
flux is usually set as the FBA objective. This procedure assumes
that organisms have been shaped by the evolution towards growth
maximization, an assumption that has been validated under a
variety of conditions [77].
Flux variability analysis. Metabolic networks of living
organisms are usually considerably underdetermined [78–80].
The size of the mathematically allowed flux space can vary
depending upon the network structure and the constraints. Flux
variability analysis (FVA) is a method that allows for rough top
estimation of the flux space for a given FBA optimization [41].
FVA computes for each reaction an interval of values inside of
which the flux of the reaction can change without influencing
value of the objective function, provided that other fluxes are
allowed to vary freely within their constraints.
It is often the case that cells do not operate perfectly optimally
when FBA simulations are compared to real data. Therefore, a
variant of the FVA approach called suboptimal FVA [41] is
sometimes informative, wherein instead of fixing the objective to
its optimal value from the initial FBA run (as in standard FVA), the
objective value is allowed to vary within a predetermined limit. For
every suboptimal FVA presented in this paper the objective lower
limit was chosen at 90% of the initial objective value (assuming
that FBA maximized the objective).
OptKnock
OptKnock is an approach for identification of mutations that
selectively increase production of a certain compound of interest,
assuming that the mutant would optimize for the same quantity as
the wild type (e.g., growth yield) [28]. OptKnock points out
reactions (and genes, through GPR logic) that must be blocked in
order to maximize a linear combination of target fluxes (outer
objective) while simultaneously maximizing for the cell’s assumed
objective (growth yield; inner objective). OptKnock poses a bi-level
optimization approach that is solved via Mixed-Integer Linear
Programming (MILP). Further details can be found in Text S1,
section ‘‘OptKnock – mathematical formulation’’ and [28].
OptKnock—modification. In order to enable the choice of
the carbon source(s) the original OptKnock procedure was
modified as follows:
1. A virtual reaction, with limited flux, was created that sourced
the virtual compound ‘‘vcarbon’’
2. For each carbon source a virtual irreversible reaction that
converted the compound ‘‘vcarbon’’ into the respective carbon
source was added to the model. The stoichiometry of this
virtual reaction corresponded to the number of carbon atoms
in the carbon source, e.g.:
6 vcarbon R D-glucose.
3. For each of those reactions (vj) a binary variable (zj) defining its
activity was created and following constraint was added to the
model: vj # vj
max?zj, where the vj
max was set to value high
enough, so that the whole ‘‘vcarbon’’ could be consumed by
each reaction.
This modification allows for the choice of one or more carbon
sources that, together with the mutation set identified by
OptKnock, provide the highest objective.
Identification of Minimal Growing Reaction Set
The minimal growing set was identified using a Mixed Integer
Linear Programming (MILP) approach, by modifying original
FBA LP problem. For every non-blocked and non-essential
reaction a binary variable was added that reflects the activity of
the reaction. When the binary variable takes value of 1 the
corresponding reaction is virtually unlimited (or limited by rules of
original LP problem). When the variable is set to 0 the
corresponding reaction is blocked (non-zero flux is impossible).
This was achieved by adding a following set of equations to the
original LP problem:
{yi : vlim
i ƒ vi ƒ yi : vlim
i
for reversible reactions, and
vi ƒ yi : vlim
i
for irreversible reactions. In order to assure that growth was not
overly restricted, a minimal flux value was established for the
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when the supply of carbon source was 60 mmolC?gDW
21h
21,
which corresponds to growth yield of 0.07 gDW?gC
21, 16 times
lower than the wild type. The objective of the problem was set to
minimize the sum of all binary variables yi:
minimize
X
i
yi
This method searches for a minimal set that is able to sustain
growth greater than or equal to to the minimal growth
requirement.
Metabolic Network Reconstruction
The main sources of information regarding the composition of
the metabolic network of Pseudomonas putida KT2440 were various
biological databases. Most of the information came from the Kyoto
Encyclopedia of Genes and Genomes (KEGG) [35,81] and
Pseudomonas Genome Database (PGD) [82]. Information regard-
ing P. putida contained in these two databases is mainly based on the
published genome annotation of the bacterium [14], so there is a
large overlap between them. Additionally, substantial information
was taken from the BRENDA database, which catalogs reaction
and enzyme information [83]. This all was augmented with
knowledge coming directly from primary research publications
(see Text S3). The reconstruction process was performed in an
iterative manner, i.e., by adding or removing reactions from the
model in between rounds of model testing. First, reaction
information for P. putida was collected from KEGG and PGD.
Reactions supported by sufficient evidence and with specific enough
functional annotations were incorporated into the model. For every
accepted reaction its reversibility was assessed basing on assign-
ments in KEGG pathways as well as information from BRENDA
database. For reactions with inconsistent assignments a decision
about reversibility was made basing on analysis of the reaction as
well as its reversibility in other organisms. Hereby, a first version of
the metabolic model was created (iJP815
pre1).
The next step involved assessing whether the reconstructed
metabolic network is able to produce energy from glucose. This
was achieved by running FBA with ATP production set as the
objective function. Subsequently, the ability of the model to grow
in silico on glucose was tested. Successful in silico growth indicates
that every chemical compound belonging to the biomass equation
can be synthesized from present sources, using the reactions
contained in the model. Since the exact cellular composition of P.
putida is not known, the composition of E. coli biomass was used as
an approximation. This test was performed by running FBA with
production of each biomass constituent set as the objective. If a
compound could not be synthesized, the gaps in the pathway
leading to it were identified manually and a search was performed
for reactions that could fill the gaps. If this approach was
unsuccessful, gaps were filled with reactions from the E. coli model.
This yielded the second version of the reconstruction (iJP815
pre2).
The third round of reconstruction consisted of two sub-steps.
First, the compounds for which transport proteins exist were
identified and appropriate reactions added. Second, the results of
BIOLOG carbon-source utilization experiments were compared
with in silico simulations for growth on those compounds. It was
assumed that the ability to grow in silico on the particular
compound as the sole carbon source approximates the in vivo
utilization. For those compounds that did not show in silico growth,
a literature search was performed in order to identify possible
pathways of utilization. The results of this search, in the form of
reactions and GPRs, were added to the model. The outcome was
the final version of the model (iJP815).
Comparison of Growth Yields with the Continuous
Culture Experiments
Growth yields on sources of basic elements (C,N,P,S) were
compared with experimental values obtained by Duetz et al. [37].
The yields of the model were computed using FBA, by setting the
growth rate to the value of the dilution rate used in experiments
and subsequently minimizing for consumption of source of
respective element (succinate, ammonia, phosphate and sulfate).
Computational Methods
The model was created and maintained using ToBiN (Toolbox
for Biochemical Networks, http://www.lifewizz.com). The opti-
mizations (FBA, FVA, OptKnock) were computed by free, open
source, solvers from the COIN-OR family (COmputational
INfrastructure for Operations Research, http://www.coin-or.org)
or by the lp_solve ver. 5.5 (http://lpsolve.sourceforge.net/5.5/)
software package. All computations were performed on a Personal
Computer with a Intel Core 2 2.40 GHz CPU and 2GB of RAM.
Experimental Methods
Media and chemicals. P. putida KT2440 was grown either on
EM-medium(BactoTrypton–20 g,Yeast-Extract–5 g,NaCl–5 g,
Glucose 0.5%, H2Odist at 1000 ml; the glucose was as 10% solution
autoclaved separately and added in appropriate amount) or SOC-
medium (Bacto Trypton – 2%, Yeast-extract – 0.5%, Glucose – 20
nM, NaCl – 10 mM, KCl – 2.5 mM, MgCl2 –1 0m M ,M g S O 4 –
10 mM, H2Odist ad 1000 ml; magnesium salts were autoclaved
separately and subsequently merged with the remaining components)
or minimal medium (106;N a 2HPO4 –5 0g ,K H 2PO4 –1 0 0g ,
MgSO467H2O–2 g ,( N H 4)2SO4 –2 0 g ,C a C l 2 –0 . 0 1 g ,
FeSO467H2O – 0.01 g, H2Odist ad 1000 ml; the potassium and
sodium salts were dissolved separat e l ya n ds u b s e q u e n t l ym i x e dw i t h
other dissolved salts; pH was set to 7.0 by adding 10 mM NaOH)
with different compounds as the sole carbon source.
BIOLOG substrate utilization experiments. Pseudomonas
putida KT2440 was tested for its ability to utilize various carbon
sources using BIOLOG GN2 Microplates [31] (BIOLOG Inc.
Hayward, CA, USA). All procedures were performed as indicated
by the manufacturer. Bacteria were grown overnight in 28uCo na
Biolog Universal Growth agar plate. Afterwards they were
swabbed from the surface of the plate and suspended in GN
inoculating fluid. Each well of the Microplate was inoculated with
150 ml of bacterial suspension and the plate was incubated in 28uC
for 24 h. Subsequently the plate was read by a microplate reader
and the read-outs were analyzed with MicroLog3 4.20 software.
Growth experiments. If not stated differently, cells were
grown on agar plates overnight in 30uC.
Transposon mutagenesis. The mutants of P. putida were
created using an in vitro transposition system (Epicentre
Technologies, Madison, Wisconsin, USA) [84]. This system
bases on a hyper-reactive Tn5-transposase and Tn5-
Transposome that, in the absence of magnesium ions, builds a
stable synaptic complex, which can be transmitted into the cell via
electroporation. To render Pseudomonas putida KT2440
electrocompetent, cells were grown in 50 ml of EM-medium to
OD600 of 0.6 to 1.0 and subsequently cooled on ice for 15 minutes.
The cells were centrifuged (4000 g, 4uC) and washed twice with
H2Odist. The cells were washed twice in 0.3 M cold solution of
sucrose and resuspended in 0.5 to 1.0 ml of 0.3 M sucrose
solution. The electrocompetent cell were used for transformation
by electroporation with Gene Pulser (BioRad, Munich, Germany)
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was mixed with 1–2 ml of DNA in ice-cooled cuvette. The
electroporation setting were 25 mF, 200 V, and 1.7 or 2.5 for the
gap size 0.1 and 0.2 cm, respectively. After two hours of
incubation in SOC-medium, transformants were selected on EM
agar plates with 60 mg/ml of kanamycin. Selection of auxotrophic
mutants was performed on minimal medium with acetate as the
sole carbon source, by replica-plating P. putida
KT2440::Tn5(Kan
r) strains on the minimal and EM media.
Identification of flanking sequences. The auxotrophic P.
putidaKT2440::Tn5(Kan
r) mutants were genotyped by enrichment of
either flanking sequences of transposon insertions using PCR [85,86].
Two rounds of amplifications were performed using primers specific
to the ends of transposons and random primers that can anneal to the
chromosome. In the first round of amplification the Kan-2 RP1
(59-GCAATGTAACATCAGAGATTTTGAG-39) primer
complementary to the end of Tn5-element and the arbitrary
primer ARB1 (59-GGCCACGCGTCGACTAGTACNNN-
NNNNNNNGATAT-39)w e r eu s e d .A1ml of supernatant from a
P. putida KT2440 lysate was used as the DNA-template. The PCR-
reaction was performed in following mixture [H2Odist –2 8 . 7ml,
incubation buffer(106)–5ml, dNTPs(5 mM) – 5 ml, primer(10 mM) –
2,5 ml, Taq DNA-polymerase (5U/ml) – 0.2 ml] under following
conditions: (i) 5 m at 95uC, (ii) 306[30 s at 30uC, 90 s at 72uC], (iii)
306[30 s at 95uC, 30 s at 45uC 120 s at 72uC]. In the second round
of amplification a 5 ml of product of the first PCR-reaction was used
as the DNA-template, together with the primers TnINT Rev (59-
GAGACACAATTCATCGATGGTTAGTG-39)a n dA R B - 2( 5 9-
GGCCACGCGTCGACTAGTAC-39). The reaction conditions
were following: 306[30 s at 95uC, 30 s at 45uC, 120 s at 72uC].
The PCR-products were purified with ‘‘QIAquick- spin PCR
Purification Kit’’ (Qiagen GmbH, Hilden, Germany) according to
manufacturer’s instructions. Subsequently, the sequencing procedure
was performed. 200–500 mg of dsDNA in normal sequencing vectors
(pBlueskript, pUC18, etc.) with 10 pmol of primer (TnINT Rev) and
6ml of ‘‘Big Dye Terminator v. 2.0Ready Reaction Mix’’ were mixed
in total volume of 10 ml. The conditions of the reaction were
following: 256[30 s at 95uC, 30 s at 60uC, 4 m at 60uC]. After the
cycle sequencing the remaining dNTP were removed using ‘‘Dye Ex
Spin Kit’’ (Qiagen GmbH, Hilden, Germany) according to
manufacturer’s instructions. To the purified product 50 mls t e r i l e
MiliQ-H2O was added and the DNA was precipitated wit 250 ml
Ethanol (100% v/v) for 30 minat 160006g in the room temperature.
The supernatant was removed and the pellet washed with 250 mlo f
ethanol (100% v/v), precipitated again by centrifugation (160006g,
RT, 10 min) and dried in vacuum-centrifuge. All the DNA-pellets
were stored in 220uCi n2 0ml Hi-Di Formamide (PE Biosystems)
until sequencing. The sequencing was performed with ABI PRISM
377 sequencer [87]. The fluorescence signals were analyzed with ABI
PRISM 3100 Genetic Analyser and the obtained sequences
compared with P. putida KT2440 genome sequence.
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